Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 15;5(1):19.
doi: 10.1038/s41746-022-00559-z.

Deep learning in image-based breast and cervical cancer detection: a systematic review and meta-analysis

Affiliations

Deep learning in image-based breast and cervical cancer detection: a systematic review and meta-analysis

Peng Xue et al. NPJ Digit Med. .

Abstract

Accurate early detection of breast and cervical cancer is vital for treatment success. Here, we conduct a meta-analysis to assess the diagnostic performance of deep learning (DL) algorithms for early breast and cervical cancer identification. Four subgroups are also investigated: cancer type (breast or cervical), validation type (internal or external), imaging modalities (mammography, ultrasound, cytology, or colposcopy), and DL algorithms versus clinicians. Thirty-five studies are deemed eligible for systematic review, 20 of which are meta-analyzed, with a pooled sensitivity of 88% (95% CI 85-90%), specificity of 84% (79-87%), and AUC of 0.92 (0.90-0.94). Acceptable diagnostic performance with analogous DL algorithms was highlighted across all subgroups. Therefore, DL algorithms could be useful for detecting breast and cervical cancer using medical imaging, having equivalent performance to human clinicians. However, this tentative assertion is based on studies with relatively poor designs and reporting, which likely caused bias and overestimated algorithm performance. Evidence-based, standardized guidelines around study methods and reporting are required to improve the quality of DL research.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. PRISMA flowchart of study selection.
Displayed is the PRISMA (preferred reporting items for systematic reviews and meta-analyses) flow of search methodology and literature selection process.
Fig. 2
Fig. 2. Pooled overall performance of DL algorithms.
a Receiver operator characteristic (ROC) curves of all studies included in the meta-analysis (20 studies with 55 tables), and b ROC curves of studies reporting the highest accuracy (20 studies with 20 tables).
Fig. 3
Fig. 3. Pooled performance of DL algorithms using different validation types.
a Receiver operator characteristic (ROC) curves of studies with internal validations (15 studies with 40 tables), b ROC curves of studies with external validations (8 studies with 15 tables).
Fig. 4
Fig. 4. Pooled performance of DL algorithms using different cancer types.
a Receiver operator characteristic (ROC) curves of studies in detecting breast cancer (10 studies with 36 tables), and b ROC curves of studies in detecting cervical cancer (10 studies with 19 tables).
Fig. 5
Fig. 5. Pooled performance of DL algorithms using different imaging modalities.
a Receiver operator characteristic (ROC) curves of studies using mammography (4 studies with 15 tables), b ROC curves of studies using ultrasound (4 studies with 17 tables), c ROC curves of studies using cytology (4 studies with 6 tables), and d presented ROC curves of studies using colposcopy (4 studies with 11 tables).
Fig. 6
Fig. 6. Pooled performance of DL algorithms versus human clinicians and human clinicians using the same sample.
a Receiver operator characteristic (ROC) curves of studies using DL algorithms (11 studies with 29 tables), and b ROC curves of studies using human clinicians (11 studies with 18 tables).
Fig. 7
Fig. 7. Summary estimate of pooled performance using forest plot.
Data presented forest plot of studies included in the meta-analysis (20 studies).

References

    1. Arbyn M, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob. Health. 2020;8:e191–e203. - PMC - PubMed
    1. Li N, et al. Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the Global Burden of Disease Study 2017. J. Hematol. Oncol. 2019;12:140. - PMC - PubMed
    1. Sung H, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209–249. - PubMed
    1. Ginsburg O, et al. Changing global policy to deliver safe, equitable, and affordable care for women’s cancers. Lancet. 2017;389:871–880. - PubMed
    1. Allemani C, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391:1023–1075. - PMC - PubMed